Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

CYTR

Cytrx (CYTR)

Cytrx Corp. (MM)
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:CYTR
日付受信時刻ニュースソース見出しコード企業名
2019/12/1920 : 05Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CYTRCytrx Corp. (MM)
2019/12/1804 : 23Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CYTRCytrx Corp. (MM)
2019/12/1804 : 20Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CYTRCytrx Corp. (MM)
2019/12/1804 : 19Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CYTRCytrx Corp. (MM)
2019/12/1804 : 18Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CYTRCytrx Corp. (MM)
2019/12/1804 : 17Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CYTRCytrx Corp. (MM)
2019/11/1607 : 10Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CYTRCytrx Corp. (MM)
2019/11/1420 : 15Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CYTRCytrx Corp. (MM)
2019/08/3004 : 13Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CYTRCytrx Corp. (MM)
2019/08/0919 : 17Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CYTRCytrx Corp. (MM)
2019/08/0205 : 15Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CYTRCytrx Corp. (MM)
2019/08/0205 : 14Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:CYTRCytrx Corp. (MM)
2019/06/2622 : 01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CYTRCytrx Corp. (MM)
2019/06/2619 : 16Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:CYTRCytrx Corp. (MM)
2019/06/2422 : 38Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...NASDAQ:CYTRCytrx Corp. (MM)
2019/06/0705 : 35Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:CYTRCytrx Corp. (MM)
2019/05/3122 : 01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CYTRCytrx Corp. (MM)
2019/05/3122 : 00PR Newswire (US)CytRx Corporation to Commence Trading on OTCQB Venture MarketNASDAQ:CYTRCytrx Corp. (MM)
2019/05/1522 : 02Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CYTRCytrx Corp. (MM)
2019/05/1522 : 00PR Newswire (US)CytRx Corporation Reports First Quarter 2019 Financial ResultsNASDAQ:CYTRCytrx Corp. (MM)
2019/05/0822 : 00PR Newswire (US)CytRx Corporation Highlights Patent Issued for Use of Aldoxorubicin in the Treatment of Brain CancerNASDAQ:CYTRCytrx Corp. (MM)
2019/05/0222 : 00PR Newswire (US)CytRx Corporation Highlights Arimoclomol Clinical Milestone Guidance Provided by Licensee Orphazyme A/SNASDAQ:CYTRCytrx Corp. (MM)
2019/04/2922 : 00PR Newswire (US)CytRx Corporation Highlights Enrollment Completion in Phase 2/3 Clinical Trial of Sporadic Inclusion Body Myositis Conducted ...NASDAQ:CYTRCytrx Corp. (MM)
2019/03/2922 : 00PR Newswire (US)CytRx Corporation Reports 2018 Financial ResultsNASDAQ:CYTRCytrx Corp. (MM)
2019/03/2919 : 22Edgar (US Regulatory)Annual Report (10-k)NASDAQ:CYTRCytrx Corp. (MM)
2019/03/1222 : 00PR Newswire (US)CytRx Corporation's Subsidiary, Centurion BioPharma Corporation's Albumin Companion Diagnostic (ACDx), Could Be The First To ...NASDAQ:CYTRCytrx Corp. (MM)
2019/02/1323 : 00PR Newswire (US)CytRx Corporation Leads Revival of Cytotoxic Therapies with LADR™ Technology Targeting Delivery Directly to the TumorNASDAQ:CYTRCytrx Corp. (MM)
2019/02/1123 : 00PR Newswire (US)CytRx Corporation Highlights Majority of Cancer Patients Do Not Have Targetable Genetic Mutations and Are Therefore Candidate...NASDAQ:CYTRCytrx Corp. (MM)
2019/02/0623 : 00PR Newswire (US)CytRx Corporation Highlights Positive Results from Full Data Set of Phase 2/3 Clinical Trial in Niemann Pick Disease Type C (...NASDAQ:CYTRCytrx Corp. (MM)
2019/01/1520 : 21Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CYTRCytrx Corp. (MM)
 Showing the most relevant articles for your search:NASDAQ:CYTR

最近閲覧した銘柄

Delayed Upgrade Clock